On Sept. 28, the US House Committee on Foreign Affairs unanimously passed House Bill H.R.3320, which directs the US secretary of state to develop a strategy to regain observer status for Taiwan in the World Health Assembly (WHA). It was initiated by Republican representatives Ted Yoho and Steve Chabot, together with Democratic representatives Brad Sherman and Gerald Connolly.
The bill was passed by the US House Foreign Affairs Subcommittee on Asia and the Pacific on July 27, and was endorsed by the House Committee on Foreign Affairs, which is chaired by US Representative Ed Royce.
The bill has been sent to the US House of Representatives for a vote.
The next step is pushing for the US Senate to pass the bill and have it signed into law by the US president.
Over the past decades, the Foundation of Medical Professionals Alliance in Taiwan (FMPAT) has visited congresses, government branches and non-governmental organizations in like-minded nations, such as the US, Japan and those in Europe, to lobby for Taiwan’s participation in the WHO.
The progression of achievements — although with some frustrations — has shown that ceaseless lobbying is of paramount importance for rallying international support for Taiwan’s cause.
Therefore, to strengthen the US’ commitment to addressing Taiwan’s participation in global health affairs, people must continue lobbying the US for its support — especially for the Senate to pass the bill — and urge the US president to sign the bill into law.
With tremendous efforts over the past two decades from the public sector and civil organizations, such as the Formosan Association for Public Affairs and FMPAT, both the US House and the Senate have passed several bills in support of Taiwan’s participation in the WHO.
Furthermore, in 1997, 2001, 2003 and 2004, US presidents signed several bills into public law — 106-137,107-10,107-158, 108-28 and 108-235 — which require the US government to support Taiwan’s participation in the WHO.
Public Law 108-235, which was passed in 2004, requires the US secretary of state to submit a report to the US Congress prior to April 1 each year on US efforts to support Taiwan’s participation in the international body.
Until now, regardless of political party, the US Department of State’s continuous adherence to the requirement has indicated the long-term benefits of enacting pro-Taiwan bills in the US.
Apart from mandating the department’s report on strategies to regain Taiwan’s observer status in the WHA, the new bill also instructs the US secretary of state to report how the department has improved its strategies to help Taiwan on this issue following any annual meetings of the WHA.
The US government has passed this bill in response to China’s senseless pressures on preventing Taiwan from attending the WHA this year.
In the short term, if this bill becomes law, the promotion of Taiwan’s participation will enter a new stage and further encourage other nations to follow suit.
However, as I have been proposing during my visits to foreign embassies in Taiwan, the long-term strategy should be lobbying each nation to push the WHA to pass a resolution to normalize nation’s participation in the WHA each year and would thus stop Taiwan from being used as a bargaining chip in political deals.
Lin Shih-chia is executive director of the Foundation of Medical Professional Alliance in Taiwan and a former Taiwan Solidarity Union legislator.
The conflict in the Middle East has been disrupting financial markets, raising concerns about rising inflationary pressures and global economic growth. One market that some investors are particularly worried about has not been heavily covered in the news: the private credit market. Even before the joint US-Israeli attacks on Iran on Feb. 28, global capital markets had faced growing structural pressure — the deteriorating funding conditions in the private credit market. The private credit market is where companies borrow funds directly from nonbank financial institutions such as asset management companies, insurance companies and private lending platforms. Its popularity has risen since
The Donald Trump administration’s approach to China broadly, and to cross-Strait relations in particular, remains a conundrum. The 2025 US National Security Strategy prioritized the defense of Taiwan in a way that surprised some observers of the Trump administration: “Deterring a conflict over Taiwan, ideally by preserving military overmatch, is a priority.” Two months later, Taiwan went entirely unmentioned in the US National Defense Strategy, as did military overmatch vis-a-vis China, giving renewed cause for concern. How to interpret these varying statements remains an open question. In both documents, the Indo-Pacific is listed as a second priority behind homeland defense and
Every analyst watching Iran’s succession crisis is asking who would replace supreme leader Ayatollah Ali Khamenei. Yet, the real question is whether China has learned enough from the Persian Gulf to survive a war over Taiwan. Beijing purchases roughly 90 percent of Iran’s exported crude — some 1.61 million barrels per day last year — and holds a US$400 billion, 25-year cooperation agreement binding it to Tehran’s stability. However, this is not simply the story of a patron protecting an investment. China has spent years engineering a sanctions-evasion architecture that was never really about Iran — it was about Taiwan. The
In an op-ed published in Foreign Affairs on Tuesday, Chinese Nationalist Party (KMT) Chairwoman Cheng Li-wun (鄭麗文) said that Taiwan should not have to choose between aligning with Beijing or Washington, and advocated for cooperation with Beijing under the so-called “1992 consensus” as a form of “strategic ambiguity.” However, Cheng has either misunderstood the geopolitical reality and chosen appeasement, or is trying to fool an international audience with her doublespeak; nonetheless, it risks sending the wrong message to Taiwan’s democratic allies and partners. Cheng stressed that “Taiwan does not have to choose,” as while Beijing and Washington compete, Taiwan is strongest when